Pulmonary embolism
542 results
301 - 400Prolonged thromboprophylaxis after hip-replacement surgery decreases VTE
Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
Interpreting BNP in patients with a history of HF
Stockings plus anticoagulation more effective to prevent post-op VTE, but anticoagulation increases bleeding
Prognostic accuracy of imaging findings for predicting morbidity and mortality in patients with COVID‐19
Perioperative bridging anticoagulation unhelpful for invasive procedures
Aspirin alone may be sufficient protection from postop VTE after total knee arthroplasty
Tranexamic acid may reduce bleeding after cesarean delivery, but with a risk of adverse effects
Rivaroxaban is effective and safe for thromboprophylaxis after bariatric surgery
Risk of myocardial infarction in users of third generation oral contraceptives
Topical application of tranexamic acid for the reduction of bleeding
Estrogen plus progestin for primary prevention in healthy postmenopausal women
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures
Ischaemic stroke and myocardial infarction risk with combined oral contraceptives
Palliative treatment
Anticoagulants for acute ischaemic stroke
Delay of more than 24 hours to hip fracture surgery associated with increased mortality
Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA
Simple risk score predicts severity of COPD exacerbations
Simple risk model predicts risk of VTE after surgery
Anticoagulants versus non‐steroidal anti‐inflammatories or placebo for treatment of venous thromboembolism
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
Ultrasonographic examinations
Superficial venous thrombophlebitis
Anticoagulation for cerebral sinus thrombosis
Sulodexide given long-term may reduce recurrent VTE in patients with initial unprovoked VTE
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
Graduated compression stockings in the prevention of postoperative venous thromboembolism
Nearly one third of elderly have dyspnea with exertion
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
Guidewire exchange of PICCs associated with higher risk of thrombosis
Low-intensity warfarin may be inferior to standard-intensity warfarin for preventing VTE after joint arthroplasty
Risk prediction model predicts VTE recurrence after initial thrombotic event
COVID-19 research briefs: High incidence of thrombotic events in patients hospitalized with COVID-19
Reduced-dose apixaban noninferior to full dose for cancer-associated VTE after 6 months, with less bleeding
Routine CT scans for occult malignancy not useful in patients with unprovoked VTE
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Antithrombotic agents in primary health care
Risk of venous thrombosis in users of 3rd vs. 2nd generation combined oral contraceptives
Deep vein thrombosis
Evaluation of thrombophilia
Statins for primary prevention of venous thromboembolism
Dilated cardiomyopathy
Acute coronary syndrome
Greater benefit with rivaroxaban than aspirin for extended treatment of VTE
Genotype-guided perioperative warfarin dosing may not be superior to algorithm-guided dosing
Edoxaban as effective as LMWH for treatment of cancer-associated VTE
Twice as many complications associated with PICCs than with midline catheters for short-term use
Twice-daily low-dose aspirin is similar to enoxaparin for thromboprophylaxis after inpatient treatment for fracture (PREVENT CLOT)
Guidelines for the clinical diagnosis of VTE (AAFP, ACP)
Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
Tinzaparin no better than warfarin in preventing recurrent VTE in adults with cancer
Idarucizumab can reverse anticoagulation of dabigatran
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis
Anticoagulation for people with cancer and central venous catheters
Anticoagulation for perioperative thromboprophylaxis in people with cancer
Physical methods for preventing deep vein thrombosis in stroke
Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
Prostacyclin for pulmonary hypertension
Enoxaparin better than aspirin for prevention of venous thromboembolism after total hip or knee arthroplasty
Fixed-dose, subcutaneous, unfractionated heparin effective for VTE
Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patients: Cochrane systematic review
Methods for administering subcutaneous heparin during pregnancy
Vertigo
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Anticoagulation versus placebo for heart failure in sinus rhythm
Statins for the primary prevention of venous thromboembolism
Pneumatic compression in addition to pharmacologic thromboprophylaxis does not further reduce DVT risk
One year of inhaled corticosteroid use is not associated with frequent serious harms in adults with asthma
No benefit from revascularization for asymptomatic renal artery stenosis (ASTRAL)
Rivaroxaban effective for acute DVT (EINSTEIN)
Slightly lower risk of major bleeds with apixaban (NNT = 83); no difference in efficacy
Postoperative tamoxifen for ductal carcinoma in situ
Interventions for preventing venous thromboembolism following abdominal aortic surgery
Graduated compression stockings for prevention of deep vein thrombosis
Thrombolysis for acute upper extremity deep vein thrombosis
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
Direct oral anticoagulants
Anxiety disorder
Acute kidney injury
Bundle branch blocks in an ECG
Syncope: causes and investigations
Prostacyclin for pulmonary arterial hypertension
Chronic heart failure
Compression stockings unnecessary for inpatients who undergo elective surgery
Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer
Small benefit to extended treatment with apixaban in selected patients with VTE
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
Immunoglobulin for multifocal motor neuropathy
Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement
Acute treatment of traumatic spinal cord injuries